Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,040 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases.
Borroto A, Reyes-Garau D, Jiménez MA, Carrasco E, Moreno B, Martínez-Pasamar S, Cortés JR, Perona A, Abia D, Blanco S, Fuentes M, Arellano I, Lobo J, Heidarieh H, Rueda J, Esteve P, Cibrián D, Martinez-Riaño A, Mendoza P, Prieto C, Calleja E, Oeste CL, Orfao A, Fresno M, Sánchez-Madrid F, Alcamí A, Bovolenta P, Martín P, Villoslada P, Morreale A, Messeguer A, Alarcon B. Borroto A, et al. Among authors: martin p. Sci Transl Med. 2016 Dec 21;8(370):370ra184. doi: 10.1126/scitranslmed.aaf2140. Sci Transl Med. 2016. PMID: 28003549
Molecular cues guiding inflammatory responses.
Barreiro O, Martín P, González-Amaro R, Sánchez-Madrid F. Barreiro O, et al. Among authors: martin p. Cardiovasc Res. 2010 May 1;86(2):174-82. doi: 10.1093/cvr/cvq001. Epub 2010 Jan 6. Cardiovasc Res. 2010. PMID: 20053659 Review.
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
Sandoval P, Loureiro J, González-Mateo G, Pérez-Lozano ML, Maldonado-Rodríguez A, Sánchez-Tomero JA, Mendoza L, Santamaría B, Ortiz A, Ruíz-Ortega M, Selgas R, Martín P, Sánchez-Madrid F, Aguilera A, López-Cabrera M. Sandoval P, et al. Among authors: martin p. Lab Invest. 2010 Oct;90(10):1517-32. doi: 10.1038/labinvest.2010.111. Epub 2010 Jun 7. Lab Invest. 2010. PMID: 20531289 Free article.
CD69 limits the severity of cardiomyopathy after autoimmune myocarditis.
Cruz-Adalia A, Jiménez-Borreguero LJ, Ramírez-Huesca M, Chico-Calero I, Barreiro O, López-Conesa E, Fresno M, Sánchez-Madrid F, Martín P. Cruz-Adalia A, et al. Among authors: martin p. Circulation. 2010 Oct 5;122(14):1396-404. doi: 10.1161/CIRCULATIONAHA.110.952820. Epub 2010 Sep 20. Circulation. 2010. PMID: 20855659
Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis.
González-Terán B, Cortés JR, Manieri E, Matesanz N, Verdugo Á, Rodríguez ME, González-Rodríguez Á, Valverde ÁM, Martín P, Davis RJ, Sabio G. González-Terán B, et al. Among authors: martin p. J Clin Invest. 2013 Jan;123(1):164-78. doi: 10.1172/JCI65124. Epub 2012 Dec 3. J Clin Invest. 2013. PMID: 23202732 Free PMC article.
Is CD69 an effective brake to control inflammatory diseases?
González-Amaro R, Cortés JR, Sánchez-Madrid F, Martín P. González-Amaro R, et al. Among authors: martin p. Trends Mol Med. 2013 Oct;19(10):625-32. doi: 10.1016/j.molmed.2013.07.006. Epub 2013 Aug 13. Trends Mol Med. 2013. PMID: 23954168 Free PMC article. Review.
The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1.
de la Fuente H, Cruz-Adalia A, Martinez Del Hoyo G, Cibrián-Vera D, Bonay P, Pérez-Hernández D, Vázquez J, Navarro P, Gutierrez-Gallego R, Ramirez-Huesca M, Martín P, Sánchez-Madrid F. de la Fuente H, et al. Among authors: martin p. Mol Cell Biol. 2014 Jul;34(13):2479-87. doi: 10.1128/MCB.00348-14. Epub 2014 Apr 21. Mol Cell Biol. 2014. PMID: 24752896 Free PMC article.
8,040 results